Rain Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Progress

NEXT STORY
Longeveron to Release Second Quarter 2021 Financial Results and Hold Conference Call on August 13, 2021
PREV STORY
Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline
Subscribe to PM360
Follow Us

Experts on Call

Get in touch with PM360 Experts On Call

Ads

You May Also Like

SoldierStrong Donates Exoskeleton for Advanced Stroke Rehabilitation to Tampa’s James A. Haley Veterans’ Hospital

Tampa-area veterans now have access to earlier mobilization following a strokeSTAMFORD, Conn., Aug. 13, ...

author_avatar
NASDAQ Market News

Celsion Announces Presentation of OVATION Study Findings at the Upcoming AACR Special Conference

LAWRENCEVILLE, N.J., Aug. 24, 2017 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), an oncology drug ...

author_avatar
NASDAQ Market News

CrownBio Expands Novel Humanized Models for Targeted Immunotherapy Development to San Diego, CA Research Center

Humanized Model Expansion Program begins with PD-1, CTLA-4, and CD137 ModelsSAN DIEGO, July 27, ...

author_avatar
NASDAQ Market News